Skip to main content

AI-based clinical software for fully automated Cardiac Magnetic Resonance reporting

Objective

AI4MedImaging is developing a disruptive clinical software - AI4CMR.Plus - for fully automated assessment of heart function and structure based on Cardiac Magnetic Resonance (CMR), with the potential to disrupt the current state of art of cardiovascular disease (CVD). By simplifying, accelerating, and enhancing CMR assessment, AI4CMR.Plus is the long-sought key to unlock the full potential of magnetic resonance as routine and gold-standard heart imaging tool, towards a new era of high-precision CVD diagnosis. To sooner-than later gain visibility, market traction, and consolidate our value chain, we have launched an MVP version of our software - AI4CMR - to the EU market, early this year. With EIC support, we now aim at accelerating AI4CMR.Plus development and preparing its market launch for 2025. Commercial exploitation of AI4CMR.Plus will prompt a steady company growth, strengthen the EU digital sovereignty and, importantly, have life-changing impact to millions threatened by CVD.

Coordinator

AI4MEDIMAGING MEDICAL SOLUTIONS SA
Net EU contribution
€ 1 753 842,00
Address
Rua Do Parque Poente Lt 35
4705 002 Braga
Portugal

See on map

Region
Continente Norte Cávado
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 776 146,75